Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 0.6 | 0.3 | 0.4 |
| Revenue growth | 97.9% | -27.8% | |
| Cost of goods sold | 0.2 | 0.2 | 0.1 |
| Gross profit | 0.4 | 0.2 | 0.3 |
| Gross margin | 66.8% | 49.7% | 76.4% |
| Research and development | 1.7 | 1.8 | 1.3 |
| General and administrative | 10.7 | 3.9 | 1.2 |
| EBIT | -12.0 | -5.5 | -2.1 |
| EBIT margin | -1890.7% | -1730.8% | -480.3% |
| Pre-tax income | 0.0 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Net income | -18.0 | -5.5 | -2.1 |
| Net margin | -2843.8% | -1704.6% | -479.9% |
| |
| Diluted EPS | ($1.72) | ($1.81) | ($0.25) |
| Shares outstanding (diluted) | 10.5 | 3.0 | 8.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|